Disc Medicine To Present Data From Multiple Clinical Programs At The SOHO Annual Meeting, To Be Held In Houston, Texas, On September 9-12, 2026
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,
Disc Medicine will show doctors the results of their medicine tests at a big conference in Texas next year. This is a chance for investors to see if their treatments are working well or need more work.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.